OpenAI is funding efforts to generate and acquire biological data to train future AI models. The strategy includes obtaining detailed regulatory filings, manufacturing strategies, and safety data from failed biotech companies through bankruptcy proceedings, information typically treated as trade secrets. This matters to AI developers because high-quality, domain-specific biological data is scarce, and unlocking it could significantly advance medical and life sciences AI applications.
Opening Kapyn…